Observational Study
Copyright ©The Author(s) 2017.
World J Methodol. Mar 26, 2017; 7(1): 25-32
Published online Mar 26, 2017. doi: 10.5662/wjm.v7.i1.25
Table 1 Baseline characteristics of all patients
Baseline characteristicsNumber of patients underwent patch testing n = 24 (%)
Gender
Male13 (54.2)
Female11 (45.8)
M:F1:1.8
Age (yr)
Range18-75
Mean ± SD45.70 ± 16.29
18-304 (16.7)
31-5012 (50)
51-706 (25)
> 702 (8.3)
Time interval (d) between drug intake and ACDRs
Range7-45
Mean ± SD22.54 ± 12.19
Implicated drugs
Phenytoin14 (58.3)
Carbamazepine9 (37.5)
Phenobarbitone2 (8.3)
Lamotrigine1 (4.7)
Phenytoin1 + Carbamazepine1 (4.7)
Phenytoin1 + Phenobarbitone1 (4.7)
Clinical spectrum of ACDRs
DRESS18 (75)
SJS-TEN overlap2 (8.3)
TEN2 (8.3)
SJS1 (4.2)
Lichenoid drug eruption1 (4.2)
Time interval (mo) between complete recovery from ACDRs and Patch test
Range1-24
Mean ± SD9.62 ± 6.62
Table 2 Clinical patterns of adverse cutaneous drug reaction and individual implicated anticonvulsants
Implicated drugsClinical patterns (n = 24 )
DRESSSJSSJS-TEN overlapTENLichenoid drug eruption
Phenytoin9111-
Carbamazepine6--11
Phenytoin + Carbamazepine--1--
Phenytoin + Phenobarbitone1----
Lamotrigine--1--
Phenobarbitone1----
Sodium valproate + Lamotrigine-----
Table 3 Positive drug patch test results
Case NoAge (yr) and SexClinical diagnosisImplicated drugInterval between drug rash and patch test (mo)Patch test results (Grades)Cross reactions (Grades)Irritant reaction at D2
165 FDRESSCarbamazepine7Carbamazepine (2+) with 10%, 20%, 30%Sodium valproate (1+) with 20%, 30%-
260 FDRESSCarbamazepine6Carbamazepine (3+) with 20%, 30%Lamotrigine (3+) with 30%Carbamazepine 10%, Lamotrigine 10%, Sodium valproate 10%, 30% Phenobarbitone 30%
355 FDRESSCarbamazepine5Carbamazepine (1+) with 30%Sodium valproate (2+) with 10%, 30% Lamotrigine (1+) with 10%, 20%, 30%Carbamazepine 10% and 20%, Phenobarbitone 10%, 30% and Sodium valproate 20%
452 MLichenoid drug eruptionsCarbamazepine6Carbamazepine (2+) with 10%, 20%, 30%Phenobarbitone (2+) with 10%, 20%, 30%Phenytoin 20%, Sodium valproate 20% and Lamotrigine 10%
548 MDRESSPhenobarbitone9Phenobarbitone (3+) with 10%, 20%, 30%Phenytoin (3+) with 10%, 20%, 30% Carbamazepine (2+) with 30% Sodium valproate (3+) with 10%, 30% Lamotrigine (1+) with 30%-
632FDRESSCarbamazepine6Carbamazepine (3+) with 10%, 20%, 30%Sodium valproate (1+) with 10%, Lamotrigine (3+) with 10%, 30% Phenobarbitone (2+) with 10%, 30%Phenytoin 10%
731 MDRESSPhenytoin8Phenytoin (1+) with 30%Lamotrigine (1+) with 30%-
826 MDRESSPhenytoin6Phenytoin (1+) with 30%--
963 MDRESSCarbamazepine4Carbamazepine (2+) with 10%Lamotrigine (1+) with 30%-
1031 MDRESSPhenytoin + Phenobarbitone8Phenytoin (3+) and Phenobarbitone (3+) with 10%, 20%, 30%Lamotrigine (1+) with 30%Sodium valproate 10% and 30%,
1143 FDRESSPhenytoin4Phenytoin (2+) with 10%, 30%Phenobarbitone (2+) with 10%, 30%Carbamazepine 30%
1275 FDRESSPhenytoin5Phenytoin (2+) with 20%, 30%Phenobarbitone (2+) with 10%, 20%, Sodium valproate (2+) with 10%, 20%, 30%Phenytoin 10%
1356 MDRESSPhenytoin1--Sodium valproate 10%, 20%, 30%
1460 MDRESSPhenytoin1--Sodium valproate 10%, 20%, 30%
Table 4 Patch test reactions with different concentrations of drugs
Case NoClinical diagnosisCarbamazepine
Phenytoin
Phenobarbitone
Lamotrigine
Sodium valproate
10%20%30%10%20%30%10%20%30%10%20%30%10%20%30%
1DRESS2+2+2+----------1+1+
2DRESS-3+3+--------3+---
3DRESS--1+------1+1+1+2+-2+
4Lichenoid drug eruptions2+2+2+---2+2+2+------
5DRESS--2+3+3+3+3+3+3+--1+3+-3+
6DRESS3+3+3+---2+-2+3+-3+1+--
7DRESS-----1+-----1+---
8DRESS-----1+---------
9DRESS2+----------1+---
10DRESS---3+3+3+3+3+3+--1+----
11DRESS---2+-2+2+-2+------
12DRESS----2+2+2+2+----2+2+2+
13DRESS------------IRIRIR
14DRESS------------IRIRIR
Total446336645217424